Syngene International plans to add bioconjugation suite for end-to-end Antibody-Drug conjugates development

Mumbai: Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru. With this new capability, Syngene…

Continue ReadingSyngene International plans to add bioconjugation suite for end-to-end Antibody-Drug conjugates development

Exercise counteracts junk food’s depression-like effects through gut-brain metabolic signaling: Study

Researchers led by Professor Yvonne Nolan at University College Cork and APC Microbiome Ireland a world leading Research Ireland Centre have identified specific metabolic pathways through which exercise counteracts the…

Continue ReadingExercise counteracts junk food’s depression-like effects through gut-brain metabolic signaling: Study

Everolimus and tacrolimus Combo Safe with Better Kidney Outcomes in Pediatric Heart Transplants: JAMA

USA: Researchers have found in a new study that among 6-month pediatric heart transplant survivors, everolimus with low-dose tacrolimus was as effective as tacrolimus with mycophenolate in preventing rejection, cardiac…

Continue ReadingEverolimus and tacrolimus Combo Safe with Better Kidney Outcomes in Pediatric Heart Transplants: JAMA